These 2 Scrappy Biotechs Could Skyrocket in April,

The same drug, pimavanserin, is already approved for psychosis in … will be starting two phase 2 clinical trials before the end of the second quarter., The same drug, pimavanserin, is already approved for psychosis in … will be starting two phase 2 clinical trials before the end of the second quarter., Read More

Scroll to Top